1 January 2021 in Biochemical and Biophysical Research Communications
Diabetic nephropathy (DN) endangers health and is a high financial public burden worldwide. Risk of DN is positively correlated with high levels of reactive oxygen species (ROS). Carnosine, an antioxidant, actively regulates cell function and has the potential to reduce the occurrence of DN. Here, we explored whether carnosine could prevent oxidative stress in human kidney tubular epithelial (HK2) cells and, if so, the mechanisms underlying this effect. HK2 cells were cultured with the ROS hydrogen peroxide (H2O2) for 24 h and then treated with carnosine. In H2O2-damaged HK2 cells, carnosine significantly increased cell viability, assessed using a Cell Counting Kit 8, increased total superoxide dismutase (T-SOD) activity, assessed using a T-SOD activity detection kit, but decreased ROS levels, assessed using a ROS-sensitive fluorescent probe. Western blotting analyses to determine the protein expression levels of BAX, BCL-2, caspase 3, and the NADPH oxidase isoforms NOX2 and NOX4, as well as confocal laser scanning microscopy to assess changes in the mitochondrial membrane potential and the relative position of mitochondria to cytochrome c, indicated that carnosine inhibited apoptosis via the mitochondrial pathway in H2O2-damaged HK2 cells. Significantly decreased NOX4 expression and increased T-SOD activity in the presence of carnosine reduced the production of intracellular ROS, relieving oxidative stress to inhibit apoptosis via the mitochondrial pathway. These findings provide molecular mechanistic insights underlying the effects of carnosine, particularly as a potential therapeutic in DN.
18 July 2020 in Journal of Diabetes Research
We have previously reported that the CNDP1 (CTG)5 allele affords protection against diabetic nephropathy (DN) in patients with Type 2 diabetes (T2DM) of Caucasian origin. Because the incidence of ESRD attributable to both Type 1 diabetes (T1DM) and T2DM is higher among South Asian than Caucasian people, the present study assessed relevant CNDP1 polymorphisms and their association with metabolic parameters in the Chinese Han population. To this end, the (CTG)n allele distribution along with 5 relevant SNPs in the CNDP1 gene, previously reported to be associated with DN in non (CTG)5 carriers of Afro-American ethnicity, were determined in 663 healthy individuals. The (CTG)6 homozygous genotype was the most prevalent (84.5%) genotype in the Chinese Han population. The (CTG)5 and (CTG)4 alleles were present in a small minority of individuals accounting for 15.2% and 0.3% of genotypes with at least one (CTG)5 or one (CTG)4 allele, respectively. Only 0.5% of individuals carried the homozygous (CTG)5 genotype and individuals carrying the homozygous (CTG)4 genotype were not found. The minor allele frequencies (MAFs) of the 5 SNP were 0.197 (C allele for rs4892247), 0.0855 (C allele for rs62099905), 0.085 (G allele for rs62099906), 0.066 (T allele for rs62099907), and 0.18 (A allele for rs72979715). All the SNPs except rs4892247 genotypes were in the Hardy-Weinberg equilibrium. Neither the (CTG)n polymorphism nor the latter three SNPs reached significance when compared with different metabolic parameters. In contrast, individuals with the TT genotype of rs62099905 presented lower fasting blood glucose but higher HbA1c levels. In conclusion, the rs62099905 in the CNDP1 gene is associated with serum glucose levels in the healthy Chinese Han population, while for the CNDP1 (CTG)n polymorphism, no association with serological parameters was found.